Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study)
Gentile et al., Microorganisms, doi:10.3390/microorganisms13030669 (preprint 9/9/2024)
https://c19early.org/gentile.html